Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReJoin in Knee Osteoarthritis
NCT01809769Phase 2Completed
- Sponsor
- AbelZeta
- Start
- Mar 2013
- Primary completion
- Mar 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogenic adipose tissue-derived mesenchymal progenitor cells in osteoarthritis (OA), sponsored by AbelZeta. Started Mar 2013; status: completed.
02
Drugs
allogenic adipose tissue-derived mesenchymal progenitor cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01809769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01809769.